Point-Of-Care Infectious Disease Diagnostics Market was valued at USD 5.2 Billion in 2022 and is projected to reach USD 9.5 Billion by 2030, growing at a CAGR of 7.9% from 2024 to 2030.
During this period, technological advancements played a key role in enhancing the efficiency of POC tests, including improvements in molecular diagnostics, immunoassays, and biosensors. Additionally, regulatory approvals for several POC diagnostic devices have fostered their widespread adoption across healthcare settings. The market saw strong investments from major players as they sought to expand their product portfolios and capitalize on the growing demand for quicker, more accessible testing solutions for diseases like COVID-19, influenza, HIV, and tuberculosis.
Looking ahead to the period from 2023 to 2033, the demand for Point-Of-Care Infectious Disease Diagnostics is expected to continue its upward trajectory. This growth is fueled by several factors, including rising global healthcare costs, the shift toward home healthcare, and an increasing focus on personalized medicine. Additionally, there is a growing emphasis on healthcare decentralization, with POC diagnostics becoming more integrated into telemedicine and mobile health platforms.
The future market will also see innovations in POC testing for a broader range of infectious diseases, including emerging threats like antimicrobial-resistant infections. The increasing availability of portable, user-friendly devices combined with cloud-based data sharing will make POC testing more accessible to underserved regions, particularly in developing countries with limited access to centralized healthcare systems.
Get an In-Depth Research Analysis of the Global Point-Of-Care Infectious Disease Diagnostics Market Size And Forecast [2025-2032]
The Point-Of-Care Infectious Disease Diagnostics Market has experienced significant growth from 2018 to 2022, driven by increasing demand for rapid and accurate diagnostic solutions. The COVID-19 pandemic accelerated the adoption of point-of-care (POC) diagnostics, making it a critical tool for healthcare providers in managing infectious diseases. POC diagnostic tests offer quick results at the patient's location, minimizing the time for diagnosis and treatment, which is crucial in emergency settings.
Thermo Fisher Scientific
Alere
Calypte Biomedical
Chembio Diagnostic Systems
Meridian Bioscience
MedMira
Trinity Biotech
Sekisui Diagnostics
OraSure Technologies
Quidel
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Point-Of-Care Infectious Disease Diagnostics Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Point-Of-Care Infectious Disease Diagnostics Market
Hospitals
Clinics
Home
Assisted Living Healthcare Facilities
Based on Types the Market is categorized into Below types that held the largest Point-Of-Care Infectious Disease Diagnostics market share In 2023.
HIV POC
Clostridium Difficile POC
HBV POC
MRSA POC
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Point-Of-Care Infectious Disease Diagnostics Market Research Analysis
1. Introduction of the Global Point-Of-Care Infectious Disease Diagnostics Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Point-Of-Care Infectious Disease Diagnostics Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Point-Of-Care Infectious Disease Diagnostics Market, By Type
6. Global Point-Of-Care Infectious Disease Diagnostics Market, By Application
7. Global Point-Of-Care Infectious Disease Diagnostics Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Point-Of-Care Infectious Disease Diagnostics Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/